Cigna scoops up Humana Medicare Advantage plans

The FDA has made two approvals this week: the first interchangeable biosimilar of Soliris and another indication for Breyanzi for mantel cell lymphoma. The agency has delay a decision on Dupixent in COPD and has set goal dates for zolbetuximab in gastric cancer and zanidatamab in bile duct cancer.

A limited pharmacy benefit manager (PBM) reform bill may be used as a "pay for" to offset the costs of extending Medicare telehealth flexibilities, shares Kelly, of Capitol Advocacy & Government Affairs.

This is the first new recommendation from the American Academy of Pediatrics since the AIDS epidemic began in the 1980s.

This month's episode of the Meet the Board podcast features a new member of our editorial advisory board, Marci J. Chodroff, MD, FACP, vice president of Medical Affairs at Magellan Rx Management, a Prime Therapeutics company.

According to a recent survey published in Menopause, the journal of The Menopause Society, sudden changes in physical activity, temperature and humidity may increase the chances of hot flashes.

COBRA coverage is not currently considered creditable coverage, so some seniors face Part B penalties. That needs to change.